Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases
Clinical trial NCT05465863 · COMPLETED
Trial details
- NCT number
- NCT05465863
- Sponsor
- Istanbul University - Cerrahpasa
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-02-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.